Prothena
PRTA
$22.87
Share price
1.55%
Change (1 day)
-69.02%
Change (1 year)
Categories
Prothena (PRTA) - P/B ratio
P/B ratio as of May 2024 : 2.16
According to Prothena's latest financial reports the company has a price-to-book ratio of 2.16.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Prothena - P/B ratio (from 2012 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.47 | -30.53% |
| 2022-12-31 | 5.00 | 1.25% |
| 2021-12-31 | 4.94 | 89.55% |
| 2020-12-31 | 2.61 | 12.59% |
| 2019-12-31 | 2.31 | 82.05% |
| 2018-12-31 | 1.27 | -64.09% |
| 2017-12-31 | 3.54 | -23.76% |
| 2016-12-31 | 4.64 | -22.55% |
| 2015-12-31 | 5.99 | 205.64% |
| 2014-12-31 | 1.96 | -41.37% |
| 2013-12-31 | 3.35 | 226.51% |
| 2012-12-31 | 1.02 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Amarin Corporation
AMRN | 0.6475 | -69.99% | 🇮🇪 Ireland |
 Alnylam Pharmaceuticals
ALNY | -86.2 | -4,095.33% | 🇺🇸 USA |
 Alkermes ALKS | 3.40 | 57.52% | 🇮🇪 Ireland |